Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Katzenellenbogen

Showing results (271-280 of 277) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 277 results.
Journal of Medicinal Chemistry|November 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, et al.
Scientific Reports|October 8, 2025
Chloroindazole based estrogen receptor β ligands with favorable pharmacokinetics promote functional remyelination and visual recoveryMicah Feri, Sung Hoon Kim, Flavio D Cardenas, et al.
Elife|November 30, 2018
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cellsSean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan, et al.
Scientific Reports|January 14, 2018
Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese MiceCristobal L Miranda, Lance A Johnson, Oriane de Montgolfier, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
EMBO Molecular Medicine|September 13, 2014
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activationAnne Abot, Coralie Fontaine, Mélissa Buscato, et al.
Breast Cancer Research : BCR|June 3, 2014
VAV3 mediates resistance to breast cancer endocrine therapyHelena Aguilar, Ander Urruticoechea, Pasi Halonen, et al.
Pageof 28

Showing results (271-280 of 277) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 277 results.
Journal of Medicinal Chemistry|November 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, et al.
Scientific Reports|October 8, 2025
Chloroindazole based estrogen receptor β ligands with favorable pharmacokinetics promote functional remyelination and visual recoveryMicah Feri, Sung Hoon Kim, Flavio D Cardenas, et al.
Elife|November 30, 2018
The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cellsSean W Fanning, Rinath Jeselsohn, Venkatasubramanian Dharmarajan, et al.
Scientific Reports|January 14, 2018
Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese MiceCristobal L Miranda, Lance A Johnson, Oriane de Montgolfier, et al.
Science Translational Medicine|April 17, 2015
PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancerAna Bosch, Zhiqiang Li, Anna Bergamaschi, et al.
EMBO Molecular Medicine|September 13, 2014
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activationAnne Abot, Coralie Fontaine, Mélissa Buscato, et al.
Breast Cancer Research : BCR|June 3, 2014
VAV3 mediates resistance to breast cancer endocrine therapyHelena Aguilar, Ander Urruticoechea, Pasi Halonen, et al.
Pageof 28